Alaunos Therapeutics reported $2.76M in Current Assets for its fiscal quarter ending in December of 2024.


Current Assets Change Date
Adcock Ingram Holdings ZAR 5.12B 234.71M Dec/2024
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Amgen USD 26.73B 195M Jun/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
Baxter International USD 7.04B 1.82B Mar/2025
Biogen USD 7.97B 341.7M Jun/2025
Bioline Rx USD 31.86M 55K Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Celltrion KRW 5.46T 122.95B Mar/2025
Corcept Therapeutics USD 443.11M 4.61M Jun/2025
Cspc Pharmaceutical CNY 21.89B 4.58B Dec/2024
Dianthus Therapeutics USD 263.6M 17.3M Jun/2025
Divis Laboratories Ltd 100.81B 7.4B Mar/2025
Gilead Sciences USD 14.72B 2.18B Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Incyte USD 3.64B 411.91M Jun/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Kangmei Pharma CNY 6.9B 6.92M Jun/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Laboratorios Farma EUR 516.3M 26.69M Jun/2025
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.41M 7.26M Dec/2024
Merck USD 37.07B 1.56B Jun/2025
Neuren Pharmaceuticals AUD 399.33M 171.29M Dec/2024
Novartis USD 25.94B 831M Jun/2025
Organigram Holdings CAD 277.78M 46.29M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Pharma Mar EUR 249.4M 13.39M Jun/2025
PTC Therapeutics USD 2.27B 43.53M Jun/2025
Qiagen NV USD 1.82B 76.12M Jun/2025
Regeneron Pharmaceuticals USD 16.86B 712.2M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sartorius EUR 2.17B 7.5M Jun/2025
Sino Biopharmaceutical CNY 24.69B 536.66M Dec/2024
TG Therapeutics USD 663.96M 19.45M Jun/2025
Tilray USD 707.34M 18.54M Nov/2024
Zz Pientze Pharmaceu 12.29B 113.34M Jun/2025